FOLH1 and adrenocortical carcinoma, hereditary: The only prospective study showed an added diagnostic value for PSMA radioligand PET/CT in 4 out of the 15 AdCC patients; for identification of bone metastases (2), an AdCC local recurrence in the Bartholin gland (1) and additional lymph node metastases (1).